Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project

doi:10.4254/wjh.v7.i22.2418

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7491)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

591

WORD

210

HTML

3792

Figures (1-2)

141

Tables (1-5)

111

Sum=4845

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

923

Download

1723

Sum=2646

Oct 8, 2015 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Oct 8, 2015; 7(22): 2418-2426
Published online Oct 8, 2015. doi: 10.4254/wjh.v7.i22.2418

Table 2 Hepatitis B virus immunity in relation to the child’s medical history n (%)

Risk factors	Total	Level of anti-HBs		Odds ratio (95%CI)
		< 10 IU/L	≥ 10 IU/L
		n = 1535	n = 2051
Hospital admission
Yes	1196 (33.4)	558 (46.4)	638 (53.6)	1.3 (1.0-1.5)^b
No	2390 (66.6)	977 (40.9)	1413 (59.1)	^®
Open abscess
Yes	280 (7.8)	150 (53.5)	130 (46.5)	1.6 (1.2-2.0)^b
No	3306 (92.2)	1385 (41.6)	1921 (58.4)	^®
Surgical operation
Yes	683 (19.0)	339 (49.6)	344 (50.4)	1.4 (1.2-1.7)^b
No	2903 (81.0)	1196 (41.2)	1707 (58.8)	^®
Regular medical injection
Yes	112 (3.1)	59 (52.7)	53 (47.3)	1.5 (1.0-2.2)^a
No	3474 (96.9)	1476 (42.5)	1998 (57.5)	^®
Blood transfusion
Yes	90 (2.5)	48 (53.3)	42 (46.7)	1.5 (1.0-2.4)^a
No	3496 (97.5)	1487 (42.5)	2009 (57.5)	^®
Rheumatic fever
Yes	140 (3.9)	74 (52.9)	66 (47.1)	1.5 (1.1-2.1)^a
No	3446 (96.1)	1461 (42.3)	1985 (57.6)	^®
HAP (total = 3256)
< 5^th percentile	569 (17.5)	218 (38.3)	351 (61.7)	1.3 (1.1-1.6)^b
≥ 5^th percentile	2687 (82.5)	1208 (45.0)	1479 (55.0)	^®
WAP (total = 3317)
< 5^th percentile	240 (7.2)	89 (37.1)	151 (62.9)	1.3 (1.0-1.7)^a
≥ 5^th percentile	3077 (92.8)	1341 (43.6)	1736 (56.4)	^®

^aP < 0.05.

^bP < 0.01.

^®: Reference group; Anti-HBs: Hepatitis B surface antibodies.

Citation: Salama II, Sami SM, Said ZNA, El-Sayed MH, El Etreby LA, Rabah TM, Elmosalami DM, Abdel Hamid AT, Salama SI, Abdel Mohsen AM, Emam HM, Elserougy SM, Hassanain AI, Abd Alhalim NF, Shaaban FA, Hemeda SA, Ibrahim NA, Metwally AM. Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project. World J Hepatol 2015; 7(22): 2418-2426
URL: https://www.wjgnet.com/1948-5182/full/v7/i22/2418.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i22.2418